Indies Pharma bets on US market incursion

 

 


Pharmaceutical distributor Indies Pharma Limited indicates that it is setting up a new beachhead in the United States with the hope of a significant impact on future revenue.

Management stated in its most recent financial report, “Indies Pharma has successfully entered into an agreement with a distributor in the United States for distribution of our USFDA approved product in the United States.

“ Again, Indies Pharma Ja had taken a bold and aggressive step and can boast as the first Caribbean company that will manufacture and distributes pharmaceutical product in United States. The product is well on track for commercial sales and distribution by or before the end of the last quarter of the fiscal year 2025.”

Management added, “ This is a proud milestone.”

For Indies Pharma net profit decreased by 9 per cent (J$ 6.5 million) in the current 2nd Quarter Period, compared to the prior year. Earnings per share recorded a decrease of 9 per cent in the current 2nd Quarter Period $0.048 from $0.053 in comparison to the prior year.

Net Profit increased by 3.2 per cent% (J$ 4.26 million) for the current six-months period, compared to the prior year. Earnings per share recorded an increase of 3.2 per cent to $0.103 for the current six-month period, an increase from $0.100 in comparison to the prior year.

Caribbean Money Daily

Comments

Popular posts from this blog

Suspension of Trading in Edufocal Limited’s Ordinary Shares

Seprod to expand dairy footprint, establishes new distribution hub in Guyana

Belnavis to lead regional banking operations for Proven, Group reveals 60-day plan to restructure wealth management arm